<DOC>
	<DOCNO>NCT01633788</DOCNO>
	<brief_summary>This study evaluate safety efficacy AGN-195263 compare vehicle patient meibomian gland dysfunction ( MGD ) eyelid .</brief_summary>
	<brief_title>A Study AGN-195263 Treatment Meibomian Gland Dysfunction</brief_title>
	<detailed_description />
	<criteria>Meibomian gland dysfunction eye Bestcorrected visual acuity 20/40 good eye Known suspect prostate cancer History breast cancer Using LATISSEÂ® eye lash growthstimulating product least 30 day prior screen visit , anticipate use study Contact lens wear either eye portion study Unable instill eye drop correctly History corneal refractive surgery either eye within 1 year</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>